Schonfeld Strategic Advisors’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Buy |
+306,399
| New | +$2.94M | 0.02% | 719 |
|
|
2024
Q4 | – | Sell |
-208,640
| Closed | -$3.77M | – | 2159 |
|
|
2024
Q3 | $3.77M | Buy |
208,640
+40,317
| +24% | +$729K | 0.03% | 529 |
|
|
2024
Q2 | $1.73M | Buy |
168,323
+23,623
| +16% | +$243K | 0.01% | 854 |
|
|
2024
Q1 | $1.54M | Buy |
144,700
+83,700
| +137% | +$889K | 0.01% | 917 |
|
|
2023
Q4 | $557K | Buy |
61,000
+22,256
| +57% | +$203K | ﹤0.01% | 1173 |
|
|
2023
Q3 | $402K | Buy |
+38,744
| New | +$402K | ﹤0.01% | 1133 |
|